Filed: 5/15/2024ACC: 0001920938-24-000004
📋 What this filing means
BRAIDWELL LP filed this quarterly 13F‑HR report disclosing 70 equity positions with a total reported market value of $3.10B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
70
Positions
$3.10B
Total AUM (reported)
1.59B
Total Shares
Allocation by class
COM$1.37B44.1%
NOTE11/1$183.59M5.9%
NOTE 2.500% 3/1$146.21M4.7%
SPONSORED ADR$137.55M4.4%
NOTE 0.375% 3/0$133.11M4.3%
NOTE11/0$124.63M4.0%
COM CL A$120.49M3.9%
Portfolio Concentration
Top 3$462.92M14.9%
4–10$708.81M22.8%
11–25$903.52M29.1%
Rest$1.03B33.1%
Top 3 weight
14.9%
Top 10 weight
37.8%
Voting Authority Distribution
Total shares with voting rights: 1.59B
Sole
Full voting authority
1.59B
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole70
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings70
Rows:
GUARDANT HEALTH INC
SOLEShares268.25M
TypePRN
Market value$183.59M
5.92%
Sole
268.25M
Shared
0.00
None
0.00
BRIDGEBIO PHARMA INC
SOLEShares135.84M
TypePRN
Market value$146.21M
4.71%
Sole
135.84M
Shared
0.00
None
0.00
EXACT SCIENCES CORP
SOLEShares144M
TypePRN
Market value$133.11M
4.29%
Sole
144M
Shared
0.00
None
0.00
NOVOCURE LTD
SOLEShares135.83M
TypePRN
Market value$124.63M
4.02%
Sole
135.83M
Shared
0.00
None
0.00
APOGEE THERAPEUTICS INC
SOLEShares1.84M
TypeSH
Market value$122.44M
3.95%
Sole
1.84M
Shared
0.00
None
0.00
NUVASIVE INC
SOLEShares114.21M
TypePRN
Market value$109.04M
3.51%
Sole
114.21M
Shared
0.00
None
0.00
NEUROCRINE BIOSCIENCES INC
SOLEShares730.21K
TypeSH
Market value$100.71M
3.25%
Sole
730.21K
Shared
0.00
None
0.00
ARGENX SE
SOLEShares219.82K
TypeSH
Market value$86.55M
2.79%
Sole
219.82K
Shared
0.00
None
0.00
VAXCYTE INC
SOLEShares1.21M
TypeSH
Market value$82.84M
2.67%
Sole
1.21M
Shared
0.00
None
0.00
NEOGENOMICS INC
SOLEShares103.58M
TypePRN
Market value$82.61M
2.66%
Sole
103.58M
Shared
0.00
None
0.00
DEXCOM INC
SOLEShares65M
TypePRN
Market value$71.59M
2.31%
Sole
65M
Shared
0.00
None
0.00
LEGEND BIOTECH CORP
SOLEShares1.24M
TypeSH
Market value$69.76M
2.25%
Sole
1.24M
Shared
0.00
None
0.00
INSMED INC
SOLEShares64.89M
TypePRN
Market value$69.43M
2.24%
Sole
64.89M
Shared
0.00
None
0.00
INSULET CORP
SOLEShares66M
TypePRN
Market value$68.85M
2.22%
Sole
66M
Shared
0.00
None
0.00
PENUMBRA INC
SOLEShares295.89K
TypeSH
Market value$66.04M
2.13%
Sole
295.89K
Shared
0.00
None
0.00
MARAVAI LIFESCIENCES HLDGS I
SOLEShares7.22M
TypeSH
Market value$62.61M
2.02%
Sole
7.22M
Shared
0.00
None
0.00
SAREPTA THERAPEUTICS INC
SOLEShares50.67M
TypePRN
Market value$59.31M
1.91%
Sole
50.67M
Shared
0.00
None
0.00
VIKING THERAPEUTICS INC
SOLEShares713.10K
TypeSH
Market value$58.47M
1.88%
Sole
713.10K
Shared
0.00
None
0.00
XENON PHARMACEUTICALS INC
SOLEShares1.31M
TypeSH
Market value$56.31M
1.81%
Sole
1.31M
Shared
0.00
None
0.00
IRHYTHM TECHNOLOGIES INC
SOLEShares483.26K
TypeSH
Market value$56.06M
1.81%
Sole
483.26K
Shared
0.00
None
0.00
ALIGN TECHNOLOGY INC
SOLEShares169.25K
TypeSH
Market value$55.50M
1.79%
Sole
169.25K
Shared
0.00
None
0.00
BRIDGEBIO PHARMA INC
SOLEShares67.29M
TypePRN
Market value$55.14M
1.78%
Sole
67.29M
Shared
0.00
None
0.00
IRONWOOD PHARMACEUTICALS INC
SOLEShares52.74M
TypePRN
Market value$53.70M
1.73%
Sole
52.74M
Shared
0.00
None
0.00
GUARDANT HEALTH INC
SOLEShares2.48M
TypeSH
Market value$51.10M
1.65%
Sole
2.48M
Shared
0.00
None
0.00
TRAVERE THERAPEUTICS INC
SOLEShares56.03M
TypePRN
Market value$49.65M
1.60%
Sole
56.03M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
GUARDANT HEALTH INCSOLE | NOTE11/1 | 268.25M | PRN | $183.59M 5.92% | 268.25M | 0.00 | 0.00 |
BRIDGEBIO PHARMA INCSOLE | NOTE 2.500% 3/1 | 135.84M | PRN | $146.21M 4.71% | 135.84M | 0.00 | 0.00 |
EXACT SCIENCES CORPSOLE | NOTE 0.375% 3/0 | 144M | PRN | $133.11M 4.29% | 144M | 0.00 | 0.00 |
NOVOCURE LTDSOLE | NOTE11/0 | 135.83M | PRN | $124.63M 4.02% | 135.83M | 0.00 | 0.00 |
APOGEE THERAPEUTICS INCSOLE | COM | 1.84M | SH | $122.44M 3.95% | 1.84M | 0.00 | 0.00 |
NUVASIVE INCSOLE | NOTE 0.375% 3/1 | 114.21M | PRN | $109.04M 3.51% | 114.21M | 0.00 | 0.00 |
NEUROCRINE BIOSCIENCES INCSOLE | COM | 730.21K | SH | $100.71M 3.25% | 730.21K | 0.00 | 0.00 |
ARGENX SESOLE | SPONSORED ADR | 219.82K | SH | $86.55M 2.79% | 219.82K | 0.00 | 0.00 |
VAXCYTE INCSOLE | COM | 1.21M | SH | $82.84M 2.67% | 1.21M | 0.00 | 0.00 |
NEOGENOMICS INCSOLE | NOTE 0.250% 1/1 | 103.58M | PRN | $82.61M 2.66% | 103.58M | 0.00 | 0.00 |
DEXCOM INCSOLE | NOTE 0.250%11/1 | 65M | PRN | $71.59M 2.31% | 65M | 0.00 | 0.00 |
LEGEND BIOTECH CORPSOLE | SPONSORED ADS | 1.24M | SH | $69.76M 2.25% | 1.24M | 0.00 | 0.00 |
INSMED INCSOLE | NOTE 1.750% 1/1 | 64.89M | PRN | $69.43M 2.24% | 64.89M | 0.00 | 0.00 |
INSULET CORPSOLE | NOTE 0.375% 9/0 | 66M | PRN | $68.85M 2.22% | 66M | 0.00 | 0.00 |
PENUMBRA INCSOLE | COM | 295.89K | SH | $66.04M 2.13% | 295.89K | 0.00 | 0.00 |
MARAVAI LIFESCIENCES HLDGS ISOLE | COM CL A | 7.22M | SH | $62.61M 2.02% | 7.22M | 0.00 | 0.00 |
SAREPTA THERAPEUTICS INCSOLE | NOTE 1.250% 9/1 | 50.67M | PRN | $59.31M 1.91% | 50.67M | 0.00 | 0.00 |
VIKING THERAPEUTICS INCSOLE | COM | 713.10K | SH | $58.47M 1.88% | 713.10K | 0.00 | 0.00 |
XENON PHARMACEUTICALS INCSOLE | COM | 1.31M | SH | $56.31M 1.81% | 1.31M | 0.00 | 0.00 |
IRHYTHM TECHNOLOGIES INCSOLE | COM | 483.26K | SH | $56.06M 1.81% | 483.26K | 0.00 | 0.00 |
ALIGN TECHNOLOGY INCSOLE | COM | 169.25K | SH | $55.50M 1.79% | 169.25K | 0.00 | 0.00 |
BRIDGEBIO PHARMA INCSOLE | NOTE 2.250% 2/0 | 67.29M | PRN | $55.14M 1.78% | 67.29M | 0.00 | 0.00 |
IRONWOOD PHARMACEUTICALS INCSOLE | NOTE 1.500% 6/1 | 52.74M | PRN | $53.70M 1.73% | 52.74M | 0.00 | 0.00 |
GUARDANT HEALTH INCSOLE | COM | 2.48M | SH | $51.10M 1.65% | 2.48M | 0.00 | 0.00 |
TRAVERE THERAPEUTICS INCSOLE | NOTE 2.500% 9/1 | 56.03M | PRN | $49.65M 1.60% | 56.03M | 0.00 | 0.00 |
Page 1 of 3